查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1629269

富血小板血漿市場，按產品類型、應用、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Platelet Rich Plasma Market, By Product Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 322 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年，富血小板血漿市場規模為6.4032億美元，2024年至2032年複合年成長率為15.20%。

富含血小板血漿市場-市場動態

老齡化人口中骨科疾病盛行率的上升預計將推動市場的成長。

隨著全球人口老化，肌肉骨骼疾病（包括骨關節炎、肌腱炎、韌帶損傷和關節退化）的盛行率正在上升。這些疾病經常導致嚴重的疼痛和殘疾，從而增加了非手術治療替代方案的吸引力，例如富血小板血漿 (PRP) 療法。世界衛生組織報告稱，全球約有 17.1 億人患有肌肉骨骼疾病，這是全球殘疾的主要原因。值得注意的是，腰痛是 160 個國家導致殘疾的主要原因。骨科疾病是全球第二大殘疾來源。此外，PRP 提取和加工相關技術的進步可能為市場帶來成長機會。然而，與治療相關的高成本可能會對市場擴張帶來挑戰。

富血小板血漿市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 15.20% 左右的複合年成長率成長

根據產品類型細分，預計純血小板血漿（Pure PRP）將在 2023 年佔據最大市場佔有率

根據應用細分，骨科是 2023 年的領先細分市場

根據最終用戶細分，醫院是 2023 年的領先細分市場

按地區分類，北美是 2023 年的主要收入來源

富血小板血漿市場-細分分析：

全球富血小板血漿市場根據產品類型、應用、最終用戶和地區進行細分。

依產品類型，市場分為三類：純富血小板血漿（Pure PRP）、富白血球富血小板血漿（L-PRP）、富血小板纖維蛋白（PRF）等。純富血小板血漿（Pure PRP）預計將主導市場成長。富血小板血漿（PRP）市場，特別是專注於純富血小板血漿（Pure PRP）的細分市場，由於其在骨科、皮膚科和美容等各個醫療領域的應用不斷增加而不斷成長。純PRP是指不含紅血球、白血球和其他血液成分的PRP形式，含有較高濃度的血小板，負責組織癒合和再生。 PRP 分離技術取得了重大進展，可以有效提取純 PRP。此外，富含白血球的片段由於其在普通外科、骨科和運動損傷中的實用性不斷增加而具有成長的潛力。

根據應用，市場分為兩個主要部分：骨科、運動醫學、美容外科、皮膚科、眼科、神經外科、一般外科和其他。骨科是市場擴張的主要驅動力。骨科領域的富血小板血漿 (PRP) 市場正在大幅成長，因為它能夠有效治療各種肌肉骨骼疾病，如肌腱損傷、韌帶扭傷、骨關節炎和肌肉拉傷。 PRP 療法作為一種促進癒合和再生的非侵入性治療方法越來越受到關注，作為傳統手術方法的替代方法。此外，運動醫學在 PRP 市場中發揮著至關重要的作用，因為運動員經常遇到與運動相關的傷害，包括韌帶撕裂、肌肉拉傷和肌腱炎。 PRP 因其加速恢復的能力而特別受到運動員的青睞，使他們能夠更快地恢復活動。

根據最終用戶，市場分為兩個部分：醫院、診所和其他，其中醫院引領市場擴張。隨著人們擴大接受 PRP 療法作為各種醫療問題的非手術、微創解決方案，醫院內的富血小板血漿 (PRP) 市場正在經歷顯著成長。 PRP 廣泛用於骨科、皮膚科、疼痛管理和再生醫學等治療領域，使其成為醫院環境中重要的治療替代方案。隨著醫院擴大將PRP納入其治療框架，加強PRP在再生醫學和其他醫學專業的應用前景廣闊。

富血小板血漿市場 - 地理洞察

預計北美將成為市場成長的主要驅動力，這主要歸因於化妝品行業擴大採用富血小板血漿（PRP）。該地區是技術進步的中心，PRP 製備設備和萃取系統的改進提高了手術的有效性、安全性和可及性。照護端設備的創新促進了臨床環境中更快的 PRP 製備，從而促進了 PRP 在美容治療中的廣泛應用。根據國際美容整形外科學會 (ISAPS) 的報告，美國的整容手術數量居全球領先地位，總計 7,347,900 例，佔全球所有外科手術的 15.5%，佔非外科手術的 30.4%。同時，由於意識的提高、PRP 治療的普及以及對非手術美容治療的需求不斷增加，歐洲和亞太地區預計將大幅成長。此外，拉丁美洲和中東地區正在經歷成長，這主要是由於 PRP 在美容應用中的日益普及以及醫療旅遊在特定領域的擴張。

富含血小板血漿市場-競爭格局：

富血小板血漿 (PRP) 市場競爭激烈，其特點是許多公司提供基於 PRP 的尖端療法和技術。旨在創建先進 PRP 系統的持續研發工作將使這些公司能夠透過產品創新保持競爭優勢，從而提高成果和更廣泛的接受度。一些公司正在尋求收購較小的實體或建​​立策略合作夥伴關係，以加強其市場地位、取得新技術並使其產品多樣化。隨著對非侵入性治療的需求持續成長，特別是在美容和骨科領域，PRP 市場內的競爭預計將加劇，成熟的全球公司和充滿活力的新創公司在塑造其未來方面發揮關鍵作用。

最新進展：

血液管理解決方案領域的知名實體泰爾茂血液和細胞技術公司 (Terumo BCT) 在美國推出了 Reveos 自動化血液處理系統。此措施旨在協助血液中心滿足血液和血小板供應的需求，同時提高其人員的營運效率。位於德州的 Carter BloodCare 正準備採用 Reveos 系統來生產用於輸血的血小板、紅血球和血漿。

目錄

第1章：富血小板血漿市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按產品類型分類的富血小板血漿市場片段
    • 富血小板血漿市場片段（依應用）
    • 最終用戶的富血小板血漿市場片段
    • 按國家/地區分類的富血小板血漿市場摘要
    • 按地區分類的富血小板血漿市場片段
  • 競爭洞察

第 3 章：富血小板血漿主要市場趨勢

  • 富血小板血漿市場促進因素
    • 市場促進因素的影響分析
  • 富血小板血漿市場限制
    • 市場限制影響分析
  • 富血小板血漿市場機會
  • 富血小板血漿市場未來趨勢

第 4 章：富血小板血漿產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：富血小板血漿市場：地緣政治緊張局勢升級的影響

  • COVID-19 大流行的影響
  • 俄羅斯-烏克蘭戰爭的影響
  • 中東衝突的影響

第 6 章：富血小板血漿市場格局

  • 2023 年富血小板血漿市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：富血小板血漿市場 - 按產品類型

  • 概述
    • 按產品類型分類的細分市場佔有率分析
    • 純富血小板血漿（純 PRP）
    • 富含白血球的富血小板血漿 (L-PRP)
    • 富含血小板纖維蛋白 (PRF)
    • 其他

第 8 章：富血小板血漿市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 骨科
    • 運動醫學
    • 整容手術
    • 皮膚科
    • 眼科手術
    • 神經外科
    • 一般外科
    • 其他

第 9 章：富血小板血漿市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院
    • 診所
    • 其他

第 10 章：富血小板血漿市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美富血小板血漿主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品類型）
    • 北美市場規模和預測（按應用）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲富血小板血漿主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按產品類型）
    • 歐洲市場規模和預測（按應用）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區富血小板血漿主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（依產品類型）
    • 亞太地區市場規模與預測（按應用）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲富血小板血漿主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品類型）
    • 拉丁美洲市場規模與預測（按應用）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲富血小板血漿主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品類型）
    • 中東和非洲市場規模及預測（按應用）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 富血小板血漿產業

  • 競爭儀表板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司簡介
    • Johnson & Johnson Services, Inc.
    • Arthrex, Inc.
    • EmCyte Corporation
    • Dr PRP USA LLC
    • Juventix Regenerative Medical, LLC.
    • Terumo Corporation
    • Zimmer Biomet
    • Stryker
    • Apex Biologix
    • Celling Biosciences, Inc.
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4367

REPORT HIGHLIGHT

The Platelet Rich Plasma Market size was valued at USD 640.32 million in 2023, expanding at a CAGR of 15.20% from 2024 to 2032.

Platelet-rich plasma (PRP) is a biological treatment that utilizes a patient's blood to address injuries and medical conditions. The preparation of PRP involves the centrifugation of the patient's blood, which concentrates the platelets within the plasma, the fluid component of blood. This process results in a PRP formulation that has a significantly higher platelet concentration compared to standard blood, thereby facilitating an accelerated healing process. The safety of PRP therapy is assured as it employs the patient's biological material, promoting the strengthening of bodily structures rather than their deterioration. PRP therapy finds applications across various medical disciplines, including orthopedics, sports medicine, dermatology, and aesthetic treatments. It is commonly employed to manage injuries affecting muscles, tendons, ligaments, and joints, in addition to enhancing recovery in conditions such as osteoarthritis.

Platelet-Rich Plasma Market- Market Dynamics

The rising prevalence of orthopedic conditions among the aging population is expected to drive the growth of the market.

As the global demographic shifts towards an older population, the prevalence of musculoskeletal disorders, including osteoarthritis, tendonitis, ligament injuries, and joint degeneration, is on the rise. These ailments frequently result in significant pain and disability, thereby increasing the appeal of non-surgical treatment alternatives such as Platelet-Rich Plasma (PRP) therapy. The World Health Organization reports that approximately 1.71 billion individuals worldwide suffer from musculoskeletal conditions, which are the foremost contributors to disability globally. Notably, low back pain stands out as the primary cause of disability in 160 countries. Orthopedic disorders rank as the second largest source of disability on a global scale. Additionally, advancements in the technology related to PRP extraction and processing may present growth opportunities for the market. Nevertheless, the high cost associated with treatment could pose challenges to market expansion.

Platelet Rich Plasma Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 15.20% over the forecast period (2024-2032)

Based on product type segmentation, Pure Platelet Rich Plasma (Pure PRP) was predicted to show maximum market share in the year 2023

Based on application segmentation, Orthopedics was the leading segment in 2023

Based on End-User segmentation, hospitals were the leading segment in 2023

Based on region, North America was the leading revenue generator in 2023

Platelet Rich Plasma Market- Segmentation Analysis:

The Global Platelet Rich Plasma Market is segmented on the basis of Product Type, Application, End-User, and Region.

The market is divided into three categories based on product type: Pure Platelet Rich Plasma (Pure PRP), Leukocyte-rich Platelet Rich Plasma (L-PRP), Platelet Rich Fibrin (PRF), and others. Pure Platelet Rich Plasma (Pure PRP) is projected to dominate market growth. The Platelet-Rich Plasma (PRP) Market, particularly the segment focused on Pure Platelet-Rich Plasma (Pure PRP), has been growing due to its increasing application in various medical fields such as orthopedics, dermatology, and aesthetics. Pure PRP refers to a form of PRP that is free from red blood cells, white blood cells, and other blood components, containing a higher concentration of platelets that are responsible for tissue healing and regeneration. There have been significant advancements in PRP separation technologies that allow for the efficient extraction of Pure PRP. Furthermore, the leucocyte-rich segment has the potential to grow due to its increasing utility across general surgery, orthopedic, and sports injuries.

The market is categorized into two main segments based on application: Orthopedics, Sports Medicine, Cosmetic Surgery, Dermatology, Ophthalmic Surgery, Neurosurgery, General Surgery, and Others. Orthopedics is the primary driver of market expansion. The Platelet-Rich Plasma (PRP) Market within orthopedics is witnessing substantial growth due to its efficacy in addressing various musculoskeletal disorders, such as tendon injuries, ligament sprains, osteoarthritis, and muscle strains. PRP therapy is gaining traction as a non-invasive treatment that fosters healing and regeneration, serving as an alternative to conventional surgical methods. Additionally, sports medicine plays a crucial role in the PRP market, as athletes frequently encounter injuries related to their sports, including torn ligaments, muscle strains, and tendinitis. PRP is especially favored by athletes for its capacity to expedite recovery, enabling them to resume their activities more swiftly.

The market is categorized into two segments based on End-User: Hospitals, Clinics, and Others, with hospitals leading the market expansion. The Platelet-Rich Plasma (PRP) Market within hospitals is experiencing notable growth, fueled by the rising acceptance of PRP therapy as a non-surgical, minimally invasive solution for various medical issues. PRP is utilized across a wide array of therapeutic fields, such as orthopedics, dermatology, pain management, and regenerative medicine, establishing it as a vital treatment alternative in hospital environments. As hospitals increasingly incorporate PRP into their treatment frameworks, there are considerable prospects for enhancing the application of PRP in regenerative medicine and other medical specialties.

Platelet Rich Plasma Market- Geographical Insights

North America is anticipated to be a key driver of market growth, primarily attributed to the increasing adoption of Platelet Rich Plasma (PRP) within the cosmetic industry. This region serves as a center for technological advancements, with improvements in PRP preparation devices and extraction systems enhancing the effectiveness, safety, and accessibility of the procedure. Innovations in point-of-care devices facilitate faster PRP preparation in clinical settings, thereby promoting the widespread application of PRP in cosmetic treatments. The United States leads globally in the number of cosmetic procedures performed, totaling 7,347,900, which accounts for 15.5% of all surgical procedures and 30.4% of non-surgical procedures worldwide, as reported by the International Society of Aesthetic Plastic Surgery (ISAPS). Meanwhile, Europe and the Asia Pacific region are projected to witness substantial growth driven by heightened awareness, improved access to PRP therapies, and an increasing demand for non-surgical aesthetic treatments. Additionally, Latin America and the Middle East are experiencing growth, largely due to the rising popularity of PRP in cosmetic applications and the expansion of medical tourism in specific areas.

Platelet-Rich Plasma Market- Competitive Landscape:

The Platelet-Rich Plasma (PRP) Market exhibits a high level of competition, characterized by a multitude of companies that provide cutting-edge PRP-based therapies and technologies. Ongoing research and development efforts aimed at creating advanced PRP systems will enable these companies to maintain a competitive edge through product innovation, resulting in enhanced outcomes and broader acceptance. Several firms are pursuing acquisitions of smaller entities or establishing strategic partnerships to strengthen their market position, access new technologies, and diversify their product offerings. As the demand for non-invasive treatments continues to grow, especially in the fields of aesthetics and orthopedics, competition within the PRP market is expected to escalate, with both established global firms and dynamic startups playing pivotal roles in shaping its future.

Recent Developments:

Terumo Blood and Cell Technologies (Terumo BCT), a prominent entity in the field of blood management solutions, has introduced the Reveos Automated Blood Processing System in the United States. This initiative aims to assist blood centers in fulfilling their requirements for blood and platelet supplies while enhancing operational efficiency for their personnel. Carter BloodCare, located in Texas, is preparing to adopt the Reveos system for the production of platelets, red blood cells, and plasma intended for transfusion.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PLATELET RICH PLASMA MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Johnson & Johnson Services, Inc.
  • Arthrex, Inc.
  • EmCyte Corporation
  • Dr. PRP USA LLC
  • Juventix Regenerative Medical, LLC.
  • Terumo Corporation
  • Zimmer Biomet
  • Stryker
  • Apex Biologix
  • Celling Biosciences, Inc.
  • Others

GLOBAL PLATELET RICH PLASMA MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Pure Platelet Rich Plasma (Pure PRP)
  • Leukocyte-rich Platelet Rich Plasma (L-PRP)
  • Platelet Rich Fibrin (PRF)
  • Others

GLOBAL PLATELET RICH PLASMA MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Orthopedics
  • Sports Medicine
  • Cosmetic Surgery
  • Dermatology
  • Ophthalmic Surgery
  • Neurosurgery
  • General Surgery
  • Others

GLOBAL PLATELET RICH PLASMA MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Others

GLOBAL PLATELET RICH PLASMA MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Platelet Rich Plasma Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Platelet Rich Plasma Market Snippet by Product Type
    • 2.1.2. Platelet Rich Plasma Market Snippet by Application
    • 2.1.3. Platelet Rich Plasma Market Snippet by End-User
    • 2.1.4. Platelet Rich Plasma Market Snippet by Country
    • 2.1.5. Platelet Rich Plasma Market Snippet by Region
  • 2.2. Competitive Insights

3. Platelet Rich Plasma Key Market Trends

  • 3.1. Platelet Rich Plasma Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Platelet Rich Plasma Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Platelet Rich Plasma Market Opportunities
  • 3.4. Platelet Rich Plasma Market Future Trends

4. Platelet Rich Plasma Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Platelet Rich Plasma Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Platelet Rich Plasma Market Landscape

  • 6.1. Platelet Rich Plasma Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Platelet Rich Plasma Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Pure Platelet Rich Plasma (Pure PRP)
    • 7.1.3. Leukocyte-rich Platelet Rich Plasma (L-PRP)
    • 7.1.4. Platelet Rich Fibrin (PRF)
    • 7.1.5. Others

8. Platelet Rich Plasma Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Orthopedics
    • 8.1.3. Sports Medicine
    • 8.1.4. Cosmetic Surgery
    • 8.1.5. Dermatology
    • 8.1.6. Ophthalmic Surgery
    • 8.1.7. Neurosurgery
    • 8.1.8. General Surgery
    • 8.1.9. Others

9. Platelet Rich Plasma Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Others

10. Platelet Rich Plasma Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Platelet Rich Plasma Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Platelet Rich Plasma Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Platelet Rich Plasma Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Platelet Rich Plasma Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Platelet Rich Plasma Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Platelet Rich Plasma Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Johnson & Johnson Services, Inc.
    • 11.2.2. Arthrex, Inc.
    • 11.2.3. EmCyte Corporation
    • 11.2.4. Dr PRP USA LLC
    • 11.2.5. Juventix Regenerative Medical, LLC.
    • 11.2.6. Terumo Corporation
    • 11.2.7. Zimmer Biomet
    • 11.2.8. Stryker
    • 11.2.9. Apex Biologix
    • 11.2.10. Celling Biosciences, Inc.
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us